[1]
Starczewski, Łukasz et al. 2026. Clinical Efficacy, Mechanism of Action, and Adverse Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes – a Systematic Review. Quality in Sport. 54, (Apr. 2026). DOI:https://doi.org/10.12775/QS.2026.54.70481.